← Eichor
Condition: Radioembolization Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Radioembolization

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Phase 4 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07059494
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Br
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06860815
The AMARA (As Much As Reasonably Achievable) Study
Phase N/A · 1 location(s) · University Hospital of Patras · NCT06257030
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospec
NA · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06334965
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
Phase 1/Phase 2 · 2 location(s) · Jonsson Comprehensive Cancer Center · NCT06432036
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Phase 2 · 1 location(s) · University of Miami · NCT06627244
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04668872
Scout Dose of Resin Microspheres
NA · 1 location(s) · Seoul National University Hospital · NCT07476651
Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)
NA · 19 location(s) · University Hospital, Angers · NCT06990659
Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans
NA · 1 location(s) · The Christie NHS Foundation Trust · NCT06123676
A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With H
NA · 1 location(s) · Yonsei University · NCT07252323
Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06862934
Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis
Phase 2 · 4 location(s) · Seoul National University Hospital · NCT06166576
Ablative Radioembolization of Renal Cell Carcinoma Trial
Phase 2 · 1 location(s) · Derek W. Cool · NCT06642220
An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies fo
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT07315633
Radioembolization Versus External Radiation Therapy
Phase 2 · 1 location(s) · Henry Ford Health System · NCT07530172
RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
Phase N/A · 20 location(s) · Ankara University · NCT07345247
Streamlining Radioembolization for CCC and Metastatic Liver Cancer
Phase N/A · 4 location(s) · Seoul National University Hospital · NCT07043387
Same-day Radioembolization for Large HCC
Phase N/A · 4 location(s) · Seoul National University Hospital · NCT06944483
Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06873269
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NA · 1 location(s) · UMC Utrecht · NCT06232889
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
Phase N/A · 1 location(s) · Palo Alto Veterans Institute for Research · NCT07303712
Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Ch
Phase 1 · 1 location(s) · Mayo Clinic · NCT06058663
Y-90 Treatment Response Using Transarterial Radioembolization
Phase 2 · 1 location(s) · Thomas Jefferson University · NCT07145801
qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver
NA · 1 location(s) · University of Wisconsin, Madison · NCT06971991
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
NA · 1 location(s) · University of Tennessee · NCT03686709
Streamlining Radioembolization for Small HCC
Phase N/A · 4 location(s) · Seoul National University Hospital · NCT06979219
Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma
Phase 2 · 1 location(s) · Seoul National University Hospital · NCT06178198
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
NA · 1 location(s) · Ochsner Health System · NCT05953961
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.